Department of Radiation Oncology, University of Heidelberg, Im Neuenheimer Feld 400, Heidelberg, Germany,
Strahlenther Onkol. 2010 Mar;186(3):149-56. doi: 10.1007/s00066-010-2018-4. Epub 2010 Feb 22.
To analyze the association of patient- and treatment-related factors with the onset of radiation pneumonitis in a homogeneously treated cohort of patients suffering from small cell lung cancer (SCLC).
242 patients with SCLC staged as limited disease, who had been treated with chemotherapy and three-dimensional conformal radiotherapy, were retrospectively analyzed. Pneumonitis was defined by typical symptoms and radiographic findings and judged clinically relevant, if drug administration and hospitalization were necessary. Patient- (age, gender, smoking history, performance status, tumor localization, benign lung disease) and treatment-related parameters (V(10)-V(40), mean lung dose [MLD]) were analyzed using χ(2)-tests for categorical parameters and logistic regression for continuous variables.
33 patients (13.6%) developed a clinically relevant pneumonitis, of whom three patients died. All cases of pneumonitis developed within 120 days. None of the patient-related parameters correlated significantly with the onset of pneumonitis. Considering treatment-related parameters, a significant correlation of V(30) in regard to total lung and V(40) in regard to ipsilateral, contralateral and total lung to the risk of pneumonitis was found. So, the estimated risk of a clinically relevant pneumonitis increased from 10% given a V(30) of 13% to 30% given a V(30) of 35%. In contrast, no significant correlation was found for V(10) and V(20) and only a trend for MLD.
In this series, high-dose radiation volume parameters, i.e., V(30) and especially V(40), were identified as the most important factors for the development of radiation pneumonitis. Low-dose radiation volume parameters and clinical parameters played an inferior role in predicting the pneumonitis risk.
分析患者和治疗相关因素与小细胞肺癌(SCLC)患者接受同源治疗后发生放射性肺炎的关系。
回顾性分析了 242 例局限期 SCLC 患者,这些患者接受了化疗和三维适形放疗。肺炎通过典型的症状和影像学表现来定义,如果需要药物治疗和住院治疗,则判断为临床相关。使用卡方检验分析患者相关参数(年龄、性别、吸烟史、体力状态、肿瘤定位、良性肺部疾病)和治疗相关参数(V(10)-V(40)、平均肺剂量[MLD]),对于连续变量使用逻辑回归分析。
33 例(13.6%)患者发生了临床相关的肺炎,其中 3 例死亡。所有肺炎病例均在 120 天内发生。患者相关参数与肺炎的发生无显著相关性。考虑到治疗相关参数,发现总肺的 V(30)和同侧、对侧及总肺的 V(40)与肺炎的风险显著相关。因此,在 V(30)为 13%的情况下,发生临床相关肺炎的风险估计为 10%,而在 V(30)为 35%的情况下,风险增加到 30%。相反,V(10)和 V(20)与 MLD 之间仅存在趋势相关性,而没有显著相关性。
在本系列中,高剂量辐射体积参数,即 V(30),尤其是 V(40),被确定为发生放射性肺炎的最重要因素。低剂量辐射体积参数和临床参数在预测肺炎风险方面作用较小。